Champix (varenicline) - lots to be recalled due to presence of impurity N-nitroso-varenicline above the Pfizer acceptable daily intake limit
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Champix
|
| Active substance |
varenicline
|
| Therapeutic area (MeSH) |
Tobacco Use Cessation
|
| Procedure number |
EMEA/H/C/000699
|
| DHPC type |
Quality defect
|
| Human ATC code |
N07BA03
|
| Dissemination date |
15/07/2021
|